Short Summary
Entropic Communications seeks Director review to deny institution of Comcast’s IPR, arguing the petitioner’s repeated filing of parallel petitions violates USPTO guidance and burdens the PTAB. The request cites statutory discretionary‑denial authority to block the abusive filing pattern.
Detailed Summary
In a request for Director review of the Institution Decision in IPR2025-00180, Entropic Communications contends that Comcast Cable Communications has engaged in a systematic abuse of the inter partes review process by filing multiple parallel petitions against the same patent, despite clear USPTO guidance issued in 2019 that such conduct is “unlikely” to be appropriate. The patent owner points to Comcast’s history of filing three or more petitions per patent, the Board’s prior denials of similar petitions, and the lack of new justification for the current filings. Citing 35 U.S.C. §§ 314(a), 314(d), and 316(a)(6), Entropic urges the Director to deny institution to enforce the discretionary‑denial framework, preserve PTAB resources, and deter future harassment of patent owners.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Comcast Cable Communications, LLC et al. vs Entropic Communications, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Imperative Care, Inc.vsInari Medical, Inc. et al.
The PTAB denied Imperative Care's petition to institute an IPR against Inari Medical's embolism‑treatment patent, finding no reasonable likelihood of success on any of the 31 challenged claims.
Samsung Electronics Co., Ltd. et al.vsASUS Technology Licensing Inc.
Samsung Electronics and ASUS Technology Licensing have settled their dispute over U.S. Patent 10,104,658 and filed a joint motion to terminate the inter partes review. The Board has not yet ruled on the merits, and the parties cite statutory authority and public‑policy reasons for ending the proceeding.
Catalyst OrthoScience Inc.vsShoulder Innovations, Inc.
Catalyst OrthoScience seeks a PTAB post‑grant review of Shoulder Innovations' reverse shoulder implant patent, arguing obviousness over multiple prior‑art references and indefiniteness of the term “central channel.” The petition also asserts that discretionary denial is unwarranted.
Samsung Electronics Co., Ltd. et al.vsHeadwater Research LLC
The Board found all challenged claims of patent 8406733 unpatentable over prior art references TS-23.140 and Ogawa by a preponderance of the evidence. The decision hinged on demonstrating that conventional design choices, such as using SSL/TLS and implementing modems, would have been obvious to one skilled in the art.
Inari Agriculture, Inc.vsPioneer Hi-Bred International, Inc.
The PTAB denied institution of a PGR petition challenging the patentability of an inbred maize variety, finding that the petitioner failed to meet the burden of showing unpatentability on merits. The Board specifically noted the lack of evidence regarding the claimed genotype and found no unsettled legal questions warranting institutional review.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.